angiogenesis
| 6 min read
Immunologist Gabriel Rabinovich leverages his 30 years of experience studying sugar-binding proteins, galectins, for developing novel therapies.
| 2 min read
The discovery of a blood vessel-promoting protein interaction found in all ovarian tumors may lead to a new druggable target for ovarian cancers.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe